eXoZymes (EXOZ) Investor presentation summary

Mission and technology platform

• Focus on improving health span by targeting metabolic disorders through a single pathway.

• Utilizes eXoZymes, a cell-free biomanufacturing platform, to produce breakthrough molecules that are difficult to synthesize conventionally.

• Holds exclusive rights to eXoZymes technology for NCT production.

Addressing the metabolic health crisis

• Global rise in obesity, diabetes, and fatty liver disease, with billions affected and numbers projected to double by 2040.

• Conventional treatments rely on sustained lifestyle changes, which are often ineffective.

Scientific approach and discovery

• Identifies mitochondrial dysfunction as the root cause of declining metabolic health.

• Targets HNF4α, a master metabolic switch, to restore mitochondrial function and address multiple disorders.

• NCT is the first potent compound to activate HNF4α, improving mitochondrial mass, reducing liver fat, and repairing gut barrier.